Paradigm Capital
 
Paradigm Home
News
About Paradigm
Paradigm Research
Investment Banking
Sales and Trading
 

Please note: Login required to access reports.

Search by
Start typing in the Ticker or Company Name field to find a company.
 
Ticker
Company Name
Analyst
Industry
Date to (YYYY-MM-DD)
 
Search Results - Alphabetical: 'V' 297 articles found:

VRX - Valeant Pharmaceuticals International Inc.
2014-07-28   VRX - Q2 Preview: Expecting a Strong Quarter; AGN a Free Option
2014-05-09   VRX - Solid Q1 Results; No Change to Outlook
2014-05-05   VRX - Q1 Preview: AGN Shareholders Likely Watching Closely
2014-04-28   VRX - After Digesting Lunch Meeting, We Believe VRX Gets AGN
2014-04-23   VRX - Hostile Bid for Allergan – Deal Would Benefit Shareholders
2014-02-28   VRX - Q4 Results – EPS Beat; Estimates and Target Up
2014-01-08   VRX - 2014 Guidance: Investing for Future Growth
2013-12-17   VRX - Solta Medical – Good Tuck-in Acquisition
2013-11-01   VRX - Q3 Results – Mixed Quarter; Outlook Remains Positive
2013-08-08   VRX - Q2 Results – Expecting Continued Strength in H2
2013-05-28   VRX - Acquired Bausch & Lomb for $8.7B in Accretive Acquisition
2013-05-03   VRX - Solid Q1 Results, Raises Guidance
2013-04-04   VRX - Zovirax Generic Approved by FDA
2013-03-21   VRX - Acquiring Dermatology-Focused Obagi Medical Products
2013-03-01   VRX - Q4 Results: Generally In Line, Awaiting More Acquisitions
2013-01-07   VRX - Outlook Unchanged Following 2013 Guidance Release
2012-12-06   VRX - Galderma Litigation Resolved; Medicis Should Close on Dec. 11
2012-11-05   VRX - Q3 Results Better than Expected, Maintain Positive View
2012-10-24   VRX - Q3 Preview: Interest on Issued Debt Impacts Estimates
2012-09-05   VRX - Medicis Acquisition Creates Dermatology Powerhouse

  Page 1 of 15   Next


RESEARCH RESULTS TAILORED TO FIT

Get just what you need -- just when you need it. That’s what our search tools allow you to do. The latest information or something from our archives. Find it easily. Find it here.


INVESTMENT BANKING SALES AND TRADING PARADIGM CAPITAL RESEARCH